Patents by Inventor Maria Feeney

Maria Feeney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIGEN BINDING PROTEINS TO ONCOSTATIN M (OSM)
    Publication number: 20210017270
    Abstract: The present invention concerns antigen binding proteins and fragments thereof which specifically bind Oncostatin M (OSM), particularly human OSM (hOSM) and which inhibit the binding of OSM to the gp130 receptor but does not directly interact with site II residues. The invention also concerns a method of humanising antibodies. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.
    Type: Application
    Filed: July 9, 2020
    Publication date: January 21, 2021
    Inventors: Gary Peter BEMBRIDGE, Chun-wa CHUNG, Susannah Karen FORD, Ian KIRBY, Ruth MCADAM, Maria FEENEY
  • Antigen binding proteins to oncostatin M (OSM)
    Patent number: 10808029
    Abstract: The present invention concerns antigen binding proteins and fragments thereof which specifically bind Oncostatin M (OSM), particularly human OSM (hOSM) and which inhibit the binding of OSM to the gp130 receptor but does not directly interact with site II residues. The invention also concerns a method of humanizing antibodies. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: October 20, 2020
    Assignee: Glaxo Group Limited
    Inventors: Gary Peter Bembridge, Chun-wa Chung, Susannah Karen Ford, Ian Kirby, Ruth McAdam, Maria Feeney
  • ANTIGEN BINDING PROTEINS TO ONCOSTATIN M (OSM)
    Publication number: 20170152312
    Abstract: The present invention concerns antigen binding proteins and fragments thereof which specifically bind Oncostatin M (OSM), particularly human OSM (hOSM) and which inhibit the binding of OSM to the gp130 receptor but does not directly interact with site II residues. The invention also concerns a method of humanising antibodies. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Gary Peter BEMBRIDGE, Chun-wa Chung, Susannah Karen FORD, Ian KIRBY, Ruth MCADAM, Maria FEENEY
  • Antigen binding proteins to Oncostatin M (OSM)
    Patent number: 9605063
    Abstract: The present invention concerns antigen binding proteins and fragments thereof which specifically bind Oncostatin M (OSM), particularly human OSM (hOSM) and which inhibit the binding of OSM to the gp130 receptor but does not directly interact with site II residues. The invention also concerns a method of humanizing antibodies. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.
    Type: Grant
    Filed: November 13, 2014
    Date of Patent: March 28, 2017
    Assignee: Glaxo Group Limited
    Inventors: Gary Peter Bembridge, Chun-wa Chung, Susannah Karen Ford, Ian Kirby, Ruth McAdam, Maria Feeney
  • ANTIGEN BINDING PROTEINS TO ONCOSTATIN M (OSM)
    Publication number: 20150064201
    Abstract: The present invention concerns antigen binding proteins and fragments thereof which specifically bind Oncostatin M (OSM), particularly human OSM (hOSM) and which inhibit the binding of OSM to the gp130 receptor but does not directly interact with site II residues. The invention also concerns a method of humanising antibodies. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.
    Type: Application
    Filed: November 13, 2014
    Publication date: March 5, 2015
    Inventors: GARY PETER BEMBRIDGE, CHUN-WA CHUNG, SUSANNAH KAREN FORD, IAN KIRBY, RUTH MCADAM, MARIA FEENEY
  • Antigen binding proteins to oncostatin M (OSM)
    Patent number: 8916695
    Abstract: The present invention concerns antigen binding proteins and fragments thereof which specifically bind Oncostatin M (OSM), particularly human OSM (hOSM) and which inhibit the binding of OSM to the gp130 receptor but does not directly interact with site II residues. The invention also concerns a method of humanizing antibodies. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.
    Type: Grant
    Filed: November 21, 2011
    Date of Patent: December 23, 2014
    Assignee: Glaxo Group Limited
    Inventors: Gary Peter Bembridge, Chun-Wa Chung, Maria Feeney, Susannah Karen Ford, Ian Kirby, Ruth McAdam
  • ANTIGEN BINDING PROTEINS TO ONCOSTATIN M (OSM)
    Publication number: 20130251724
    Abstract: The present invention concerns antigen binding proteins and fragments thereof which specifically bind Oncostatin M (OSM), particularly human OSM (hOSM) and which inhibit the binding of OSM to the gp130 receptor but does not directly interact with site II residues. The invention also concerns a method of humanising antibodies. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.
    Type: Application
    Filed: November 21, 2011
    Publication date: September 26, 2013
    Applicant: Glaxo Group Limited
    Inventors: Gary Peter Bembridge, Chun-Wa Chung, Maria Feeney, Susannah Karen Ford, Ian Kirby, Ruth McAdam
  • Apparatus And Method For Sorting, Holding And Laundering Articles
    Publication number: 20080006637
    Abstract: The present invention pertains to an apparatus for sorting and holding laundry having a sorting bag including a first opening for inserting and removing laundry from therein. The sorting bag is adapted to be suspended from a frame. The apparatus also includes a compartmentalizing mechanism selectively separating hollow portions of the inside of the sorting bag thereby preventing laundry inserted into a first portion of the sorting bag from moving into a second portion of the sorting bag.
    Type: Application
    Filed: July 6, 2006
    Publication date: January 10, 2008
    Inventor: Rosa Maria Feeney